Kaifeng Wei
Impact in
-
- Chronic Kidney Disease and Diabetes
-
- Pharmacological Effects of Medicinal Plants
Papers in
-
- COVID-19 Clinical Research Studies 2
- SARS-CoV-2 and COVID-19 Research 2
- Viral gastroenteritis research and epidemiology 1
- Virology 1
- Poxvirus research and outbreaks 1
- Co-authors
- Shuang Shen (1 shared paper)Jianming Guo (1 shared paper)Yuping Tang (1 shared paper)Shulan Su (1 shared paper)Yue Zhu (1 shared paper)Sheng Guo (1 shared paper)Dawei Qian (1 shared paper)Pei Liu (1 shared paper)
- Journals
- Journal of Ethnopharmacology (2 papers)Infectious Diseases of Poverty (1 paper)Cell Host & Microbe (1 paper)Frontiers in Pediatrics (1 paper)Colloids and Surfaces B Biointerfaces (1 paper)
- Partner nations
- China
In The Last Decade
Kaifeng Wei
9 papers receiving 194 citations
Peers
Comparison fields: 5 of 59
- Nephrology 24
- Pharmacology 33
- Infectious Diseases 33
- Clinical Biochemistry 11
- Virology 7
Countries citing papers authored by Kaifeng Wei
This map shows the geographic impact of Kaifeng Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaifeng Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaifeng Wei more than expected).
Fields of papers citing papers by Kaifeng Wei
This network shows the impact of papers produced by Kaifeng Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaifeng Wei. The network helps show where Kaifeng Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Kaifeng Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 88 | |
| 2 | 2015 | 55 | |
| 3 | 2023 | 29 | |
| 4 | 2025 | 6 | |
| 5 | 2024 | 5 | |
| 6 | 2022 | 4 | |
| 7 | 2025 | 4 | |
| 8 | 2025 | 4 | |
| 9 | Influence of Yangfei Huoxue Fang on Angiogenesis of PYM-induced Pulmonary Fibrosis in Rats | 2012 | 1 |
| 10 | 2025 | 0 | |
| 11 | 2025 | 0 |
About Kaifeng Wei
Kaifeng Wei is a scholar working on Infectious Diseases, Virology, Molecular Medicine, Clinical Biochemistry and Nephrology, having authored 11 papers that have together received 196 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Natural product bioactivities and synthesis (2 papers), Viral gastroenteritis research and epidemiology (1 paper), Poxvirus research and outbreaks (1 paper), Nanoparticle-Based Drug Delivery (1 paper), Neonatal and Maternal Infections (1 paper) and Chronic Kidney Disease and Diabetes (1 paper). The work is most often cited by research in Nephrology (24 citations), Pharmacology (33 citations), Infectious Diseases (33 citations), Clinical Biochemistry (11 citations) and Virology (7 citations). Kaifeng Wei has collaborated with scholars based in China. Frequent co-authors include Shuang Shen, Jianming Guo, Yuping Tang, Shulan Su, Yue Zhu, Sheng Guo, Dawei Qian, Pei Liu, Ting Chen and Jin‐Ao Duan. Their work appears in journals such as Journal of Ethnopharmacology, Infectious Diseases of Poverty, Cell Host & Microbe, Frontiers in Pediatrics and Colloids and Surfaces B Biointerfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.